Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial)
COVID-19 환자의 호흡기 증상에 대한 분무 펜타닐(벤타닐 시험)
3900
[키워드] ACHE
addition
adverse events
Brain
brain stem
breathlessness
chemoreceptor
chronic obstructive
chronic obstructive pulmonary disease
citrate
clinical trial
coronavirus
coronavirus disease
cough
COVID 19
COVID-19
distressing
Dyspnea
Efficacy
Efficacy and safety
evaluate
exhibiting
fentanyl
fentanyl citrate
hypercarbia
hypoxia
IMPROVE
Infection
ipratropium
ipratropium bromide
lidocaine
Magnesium
magnesium sulfate
modulating
nebulized
nebulized fentanyl
normal saline
normal saline 0.9%
obstructive pulmonary disease
opioids
oxygen
Oxygen therapy
Pain
pain relief
Patient
patients with COVID-19
predict
pulmonary disease
Randomized
respiratory
respiratory rate
respiratory symptom
respiratory symptoms
response
salbutamol
Shortness of breath
shown
Side effect
sore throat
sulfate
suppress
therapy
throat pain
Trial
[DOI] 10.1097/MD.0000000000028637 PMC 바로가기 [Article Type] 3900
[DOI] 10.1097/MD.0000000000028637 PMC 바로가기 [Article Type] 3900